Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
3,762
datasets available to search
ShareScore release 0.9.0
Dataset results
3,762 results for “Combination treatment”
Dataset used for: Effectiveness of Acute Malnutrition Treatment at Health Center and Community Level with a Simplified, Combined Protocol in Mali: An Observational Cohort Study
<p>This dataset contains the variables used in the analysis of the body composition and outcomes of the Acute Malnutrition Treatment at Health Center and Community Level with a Simplified, Combined Protocol in Mali pilot study, from December 2018 to December 2021</p>
Figure 3 in Effects of combined treatment of cadmium and oxytetracycline on the terrestrial isopod Porcellio leavis
Figure 3. Concentration of biochemical parameters: Total protein, Lipid peroxidation (LPO), Catalase activity (CAT) and Total free amino acids (TFAA) in P. leavis in different treated groups control, Cd, T1, T2, and T3. Values are the mean of three replicates (n=3) ± SE. The significant difference between the groups were analysed by one-way analysis of variance. Mean values of different subscript letters (a,b,c,d) were significantly different (p<0.001).
Figure 1 in Capturing Males of Pestiferous Fruit Flies (Diptera: Tephritidae): Is the Combination of Triple-Lure Wafers and Insecticidal Strips as Effective as Standard Treatments?
Figure 1. Captures of Ceratitis capitata, Bactrocera dorsalis, and Bactrocera cucurbitae males in Jackson traps baited with standard lures or triple-lure wafers over a 12-week interval in October-December, 2013, in a coffee field near Haleiwa, Oahu. Symbols represent mean values of 15 traps; error bars represent 1 SE.
Data and Codebook for: Post-recovery relapse of children treated with a simplified, combined nutrition treatment protocol in Mali : a prospective cohort study
<p>Data and Codebook to recreate analyses for the study. </p> <p>Abstract: The present study aimed to determine the 6-month incidence of relapse and associated factors among children who recovered following mid-upper arm circumference (MUAC) based simplified combined treatment using the ComPAS protocol. A prospective cohort of 420 children who had reached a MUAC ≥125 mm for two consecutive measures was monitored between December 2020 and October 2021. Children were seen at home by study enumerators fortnightly for 6 months. Relapse was defined as developing a MUAC <125 mm or edema. The overall 6-month cumulative incidence of relapse [95%CI] was 26.1% [21.7;30.8] and the incidence rate per 100 child-months was 4.8 [4.0;5.9]. Relapse was similar among children initially admitted to treatment with a MUAC<115mm or oedema and among those with a MUAC≥115mm but <125mm. Relapse was predicted by lower anthropometry both at admission to and discharge from treatment, and higher number of illness episodes per month of follow-up. Having a vaccination card, using an improved water source, having agriculture as the main source of income and increases in caregivers workload during follow-up all protected from relapse. Children discharged recovered following treatment remain at risk of relapsing into acute malnutrition. To achieve reduction in relapse, recovery criteria may need to be revised.</p>
A Study to Compare the Safety and Efficacy of an Aromatase Inhibitor in Combination With Lapatinib, Trastuzumab or Both for the Treatment of Hormone Receptor Positive, HER2+ Metastatic Breast Cancer
ClinicalTrials.gov study NCT01160211. IPD Sharing: YES. Countries: 29. Publications: 2.
Efficacy and Safety of Glecaprevir (ABT-493)/Pibrentasvir (ABT 530) (GLE/PIB) in Combination With Sofosbuvir and Ribavirin in Participants With Hepatitis C Virus Who Did Not Respond to Treatment in a
ClinicalTrials.gov study NCT02939989. IPD Sharing: YES. Countries: 12. Publications: 1.
Study of Safety, Tolerability, and Efficacy of a Combination Treatment of LJN452 and CVC in Adult Patients With NASH and Liver Fibrosis
ClinicalTrials.gov study NCT03517540. IPD Sharing: UNDECIDED. Countries: 17. Publications: 2.
A Dose Escalation Study of a Combination Antihypertensive Drug in the Treatment of Various Groups of Patients Who do Not Respond to Single Drug Treatment of Their High Blood Pressure
ClinicalTrials.gov study NCT00791258. IPD Sharing: YES. Countries: 1. Publications: 2.
A Study of Tislelizumab (BGB-A317) in Combination With Chemotherapy as First Line Treatment in Participants With Advanced Esophageal Squamous Cell Carcinoma
ClinicalTrials.gov study NCT03783442. IPD Sharing: YES. Countries: 16. Publications: 2.
Glecaprevir/Pibrentasvir Fixed-dose Combination Treatment for Acute Hepatitis C Virus Infection
ClinicalTrials.gov study NCT04042740. IPD Sharing: YES. Countries: 2. Publications: 1.
A Study of SAR444245 Combined With Other Anticancer Therapies for the Treatment of Participants With Gastrointestinal Cancer (Master Protocol) (Pegathor Gastrointestinal 203)
ClinicalTrials.gov study NCT05104567. IPD Sharing: YES. Countries: 9. Publications: 0.
Pozelimab and Cemdisiran Combination Treatment in Adult Participants With Paroxysmal Nocturnal Hemoglobinuria Who Have Received Pozelimab Monotherapy
ClinicalTrials.gov study NCT04811716. IPD Sharing: YES. Countries: 6. Publications: 1.
This Study Will Evaluate the Effect of Canakinumab or Pembrolizumab Given as Monotherapy or in Combination as Neo-adjuvant Treatment for Subjects With Early Stages NSCLC.
ClinicalTrials.gov study NCT03968419. IPD Sharing: YES. Countries: 12. Publications: 1.
Everolimus in Combination With Trastuzumab and Paclitaxel in the Treatment of HER2 Positive Locally Advanced or Metastatic Breast Cancer
ClinicalTrials.gov study NCT00876395. IPD Sharing: UNDECIDED. Countries: 28. Publications: 3.
A Study of SAR444245 Combined With Cemiplimab for the Treatment of Participants With Various Advanced Skin Cancers (Pegathor Skin 201)
ClinicalTrials.gov study NCT04913220. IPD Sharing: YES. Countries: 7. Publications: 0.
Study to Assess the Safety and Efficacy of Ribociclib (LEE011) in Combination With Letrozole for the Treatment of Men and Pre/Postmenopausal Women With HR+ HER2- aBC
ClinicalTrials.gov study NCT02941926. IPD Sharing: YES. Countries: 38. Publications: 5.
VERIFY:A Study to Compare Combination Regimen With Vildagliptin & Metformin Versus Metformin in Treatment-naïve Patients With Type 2 Diabetes Mellitus
ClinicalTrials.gov study NCT01528254. IPD Sharing: YES. Countries: 34. Publications: 5.
Time course of metabolic variations in human neutrophils with PMA treatment alone or in combination with DPI: Part 1
Open the record for dataset details and reuse information.
Metabolic variations in human neutrophils with different combinations of PMA treatments (2DG, 6AN, DPI and AA): Part 2
Open the record for dataset details and reuse information.
Results "Anti-obesity effects of individual or combination treatment with Spirulina platensis and green coffee bean aqueous extracts in high-fat diet-induced obese rats"
<p><strong>Background</strong>: Obesity, a chronic disease, is associated with serious health risks, including premature mortality. This study aimed to investigate the anti-obesity effects of individual or combination treatment with <em>Spirulina platensis</em> and green coffee bean aqueous extracts in high-fat diet-induced (HFD) obese rats.</p> <p><strong>Methods</strong>: Rats were fed on HFD to induce obesity. Corn oil in the HFD accounted for 50.98 % of the calories. Fifty rats were divided into the following five groups (10 rats/group): control, HFD, HFD-<em>Spirulina</em>, HFD-coffee, HFD-<em>Spirulina</em> and coffee co-treatment groups. The serum levels of lipid, leptin, and insulin, as well as the hepatic mRNA levels of fatty acid synthase (FAS), peroxisome proliferator-activated receptor gamma coactivator-1 alpha (PGC-1α), and peroxisome proliferator-activated alpha receptor (PPARα) were estimated.</p> <p><strong>Results</strong>: The <em>Spirulina</em> and/or green coffee bean aqueous extracts decreased the final bodyweight and liver weight, and the serum levels of alanine aminotransferase, aspartate aminotransferase, and alkaline phosphatase. Additionally, the extracts decreased the serum levels of total cholesterol, triacylglycerol, low-density lipoprotein-cholesterol, leptin, and glucose, and enhanced the serum insulin level. Furthermore, the extracts enhanced the PGC-1α and PPARα mRNA levels and decreased the FAS mRNA levels.</p> <p><strong>Conclusion</strong>: The individual or combination treatment with <em>Spirulina</em> and green coffee bean extracts decreased obesity-induced hyperlipidemia. Thus, <em>Spirulina platensis</em> and green coffee can be potentially used to treat obesity.</p>
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.